These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5922884)

  • 1. Propranolol and angina pectoris.
    Wolfson S; Heinle RA; Herman MV; Kemp HG; Sullivan JM; Gorlin R
    Am J Cardiol; 1966 Sep; 18(3):345-53. PubMed ID: 5922884
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiologic approach to the treatment of angina pectoris.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    N Engl J Med; 1969 Nov; 281(22):1225-8. PubMed ID: 4981526
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
    Dunér H; Pernow B
    Acta Med Scand; 1973 Dec; 194(6):517-23. PubMed ID: 4589794
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic therapy of angina pectoris].
    Siepe O
    Minerva Med; 1972 Apr; 63(31):1800-3. PubMed ID: 4402001
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 6. The qualitative dynamics of angina pectoris and the effect of certain drugs as recorded with the high-frequency (acceleration) direct body ballistocardiograph.
    Winer NJ
    Bibl Cardiol; 1973; 0(31):181-8. PubMed ID: 4213474
    [No Abstract]   [Full Text] [Related]  

  • 7. Angina pectoris: pathophysiology, evaluation, and treatment.
    Ann Intern Med; 1971 Aug; 75(2):263-96. PubMed ID: 4397688
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the effect of dipyridamole and propranolol on coronary circulation in human subjects with and without coronary heart disease.
    Takezawa H; Kitamura H; Komada M; Tanimura H; Masui K
    Jpn Circ J; 1968 Nov; 32(11):1565-9. PubMed ID: 5756393
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular pharmacology of propranolol in man.
    Wolfson S; Gorlin R
    Circulation; 1969 Oct; 40(4):501-11. PubMed ID: 5823547
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons.
    Parratt JR
    Cardiovasc Res; 1969 Jul; 3(3):306-14. PubMed ID: 4980762
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease.
    Lewis CM; Brink AJ
    Am J Cardiol; 1968 Jun; 21(6):846-59. PubMed ID: 5678218
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory effects of propranolol in children with Fallot's tetralogy. Observations with isoproterenol infusion, exercise and crying.
    Shah PM; Kidd L
    Am J Cardiol; 1967 May; 19(5):653-7. PubMed ID: 6024709
    [No Abstract]   [Full Text] [Related]  

  • 14. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
    Hebb AR; Godwin TF; Gunn RW
    Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.
    Pine M; Favrot L; Smith S; McDonald K; Chidsey CA
    Circulation; 1975 Nov; 52(5):886-93. PubMed ID: 1175271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sympathetic stimulation and blockade in patients with angina pectoris. A clinical conference in cardiography from the University of Kentucky Medical Center, Lexington, Kentucky.
    Gettes LS; Yoshonis KF; Logic JR; Luria MH; Surawicz B
    Dis Chest; 1968 Nov; 54(5):450-6. PubMed ID: 5698590
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
    Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
    Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.